Full Press Release Details
INDIANAPOLIS , Aug. 25, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will attend Citi's 17th Annual BioPharma Conference on Wednesday, Sept. 7 , 2022. Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific and medical officer, and president of Lilly Research Laboratories, will participate in a fireside chat at 3:30 p.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
| Refer to: | Jordan Bishop; [email protected] ; 317-473-5712 (Media) |
| Joe Fletcher; [email protected] ; 317-296-2884 (Investors) |
SOURCE Eli Lilly and Company